Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Diabetes may lower the risk of prostate cancer.

Finasteride may reduce bleeding after TURP, but more research needed.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Young and adult hamsters both respond similarly to testosterone and finasteride treatments, but young hamsters aren't good for testing the inhibitory activity of a specific enzyme.

Chitosan-decorated nanoparticles can improve skin delivery and reduce side effects of finasteride.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Older men should openly discuss sexual health with doctors to improve their quality of life.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Finasteride improves urinary symptoms and quality of life in BPH patients, especially with larger prostate size.

Baseline PSA levels affect general health and sexual satisfaction in men with BPH treated with finasteride or placebo.

Androgen-modulating drugs do not significantly change the heat sensitivity of prostate cancer cells.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Finasteride is effective for hair loss but has controversial side effects.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Citrullus colocynthis fruit extract and its compound may help treat enlarged prostate.